Clinical trial • Phase I • Oncology
MEDI5752 for Advanced solid tumours
Phase I trial of MEDI5752 for Advanced solid tumours. 220 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumours
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 16-07-2024
- First CTIS Authorization Date
- 06-08-2024
Trial design
Phase I trial across 19 sites in France, Netherlands, Portugal and others.
- Target Sample Size
- 220
Recruitment
- Planned Sample Size
- 220
- Recruitment Window Months
- 84
Geography
- Total Number Of Sites
- 19
- Total Number Of Participants
- 205
France
- Latest Decision Or Authorization Date
- 30-06-2025
- Number Of Sites
- 3
- Number Of Participants
- 25
Sites
- Site Name
- Institut Gustave Roussy
- Department Name
- Cancer Medicine
- Contact Person Name
- Benjamin Besse
- Contact Person Email
- Benjamin.besse@gustaveroussy.fr
- Site Name
- Centre Leon Berard
- Department Name
- Medical oncology
- Contact Person Name
- Sylvie Negrier
- Contact Person Email
- urologie@lyon.unicancer.fr
- Site Name
- Centre Hospitalier Universitaire De Bordeaux
- Department Name
- Medical oncology
- Contact Person Name
- Marine Gross-Goupil
- Contact Person Email
- Marine.gross-goupil@chu-bordeaux.fr
Netherlands
- Latest Decision Or Authorization Date
- 07-07-2025
- Number Of Sites
- 1
- Number Of Participants
- 10
Sites
- Site Name
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
- Department Name
- Medical oncology and clinical pharmacology
- Contact Person Name
- Marloes Van Dongen
- Contact Person Email
- fase1secretariaat@nki.nl
Portugal
- Latest Decision Or Authorization Date
- 30-06-2025
- Number Of Sites
- 2
- Number Of Participants
- 20
Sites
- Site Name
- Instituto Portugues De Oncologia Do Porto Francisco Gentil E.P.E.
- Department Name
- Oncology
- Contact Person Name
- Júlio Oliveira
- Contact Person Email
- julio.oliveira@ipoporto.min-saude.pt
- Site Name
- Unidade Local De Saude De Santa Maria E.P.E.
- Department Name
- Oncology
- Contact Person Name
- Luís Marques da Costa
- Contact Person Email
- luis.costa@chln.min-saude.pt
Italy
- Latest Decision Or Authorization Date
- 19-11-2025
- Number Of Sites
- 3
- Number Of Participants
- 20
Sites
- Site Name
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
- Department Name
- Dipartimento Oncologia ed Ematologia Clinica e Sperimentale
- Contact Person Name
- Angelo Delmonte
- Contact Person Email
- angelo.delmonte@irst.emr.it
- Site Name
- IRCCS Istituto Nazionale Tumori Fondazione Pascale
- Department Name
- Dipartimento Ematologia e Terapie Innovative
- Contact Person Name
- Paolo Antonio Ascierto
- Contact Person Email
- p.ascierto@istitutotumori.na.it
- Site Name
- Azienda Unita Sanitaria Locale Della Romagna
- Department Name
- Ospedale S. Maria delle Croci, Dipartimento di Oncoematologia Viale Vincenzo Randi 5, Ravenna, 48121
- Contact Person Name
- Manolo D’Arcangelo
- Contact Person Email
- manolo.darcangelo@auslromagna.it
Spain
- Latest Decision Or Authorization Date
- 19-11-2025
- Number Of Sites
- 10
- Number Of Participants
- 130
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology Department
- Contact Person Name
- Enriqueta Felip Font
- Contact Person Email
- efelip@vhebron.net
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Medical Oncology Department
- Contact Person Name
- Eduardo Castanon Alvarez
- Contact Person Email
- ecastanon@unav.es
- Site Name
- Complexo Hospitalario Universitario A Coruna
- Department Name
- Medical Oncology Department
- Contact Person Name
- Maria Rosario Garcia Campelo
- Contact Person Email
- maria.rosario.garcia.campelo@sergas.es
- Site Name
- Hospital Universitario Puerta De Hierro De Majadahonda
- Department Name
- Medical Oncology Department
- Contact Person Name
- Mariano Provencio Pulla
- Contact Person Email
- mprovencio.ensayosclinicos@gmail.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- Medical Oncology Department
- Contact Person Name
- Margarita Majem Tarruella
- Contact Person Email
- mmajem@santpau.cat
- Site Name
- Hospital Clinico Universitario De Valencia
- Department Name
- Medical Oncology Department
- Contact Person Name
- Maria Amelia Insa Molla
- Contact Person Email
- ameliainsamolla@gmail.com
- Site Name
- Hospital Universitario Virgen De La Victoria
- Department Name
- Medical Oncology Department
- Contact Person Name
- Laura Medina Rodriguez
- Contact Person Email
- laura.medina@ibima.eu
- Site Name
- Hospital Del Mar
- Department Name
- Medical Oncology Department
- Contact Person Name
- Alejo Martin Rodriguez-Vida Rodriguez
- Contact Person Email
- arodriguezvida@hospitaldelmar.cat
- Site Name
- Institut Catala D'oncologia
- Department Name
- Medical Oncology Department
- Contact Person Name
- Enric Cancereny Costa
- Contact Person Email
- ecarcereny@iconcologia.net
- Site Name
- Instituto Oncologico Dr. Rosell S.L.
- Department Name
- Medical Oncology Department
- Contact Person Name
- Andres Aguilar Hernandez
- Contact Person Email
- aaguilar@oncorosell.com
Sponsor
Primary sponsor
- Full Name
- AstraZeneca AB
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Sweden
Investigational products
- Investigational Product Name
- MEDI5752
Related trials
Other published trials that may interest you.